# Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)

Study · id `cardio:ct-nct06134622` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06134622](<https://clinicaltrials.gov/study/NCT06134622>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06134622

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 832 participants.

## Technical summary

Registry record NCT06134622. Randomized; quadruple masking; primary purpose treatment. Start 2024-03-14 (actual); primary completion 2024-09-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 832 participants (enrolled count; ClinicalTrials.gov record NCT06134622, source copy `cardio:ctgov-nct06134622-2025-05-04`, retrieved 2026-11-18)
- Started: 2024-03-14 (actual) (ClinicalTrials.gov record NCT06134622, source copy `cardio:ctgov-nct06134622-2025-05-04`, retrieved 2026-11-18)
- Primary completion: 2024-09-25 (actual) (ClinicalTrials.gov record NCT06134622, source copy `cardio:ctgov-nct06134622-2025-05-04`, retrieved 2026-11-18)
- Completion: 2024-12-30 (actual) (ClinicalTrials.gov record NCT06134622, source copy `cardio:ctgov-nct06134622-2025-05-04`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06134622, source copy `cardio:ctgov-nct06134622-2025-05-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06134622-2025-05-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)
- Acronym: ASSET-IT
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Intravenous thrombolysis plus tirofiban
- Intervention (Drug): Intravenous thrombolysis plus placebo
- Lead sponsor: The First Affiliated Hospital of University of Science and Technology of China
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital of University of Science and Technology of China (`cardio:org-the-first-affiliated-hospital-of-university-of-science-and-03d159`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke (`cardio:pubmed-40616232`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 53783fa7d8104d2289e81df453750ae0206a3fac7665468710bf6ba5a0d96acd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
